Communication Dans Un Congrès Année : 2022

Real-world experience with Vosoritide for achondroplasia: interim findings from an early access programme in France

Fichier non déposé

Dates et versions

hal-04965096 , version 1 (25-02-2025)

Identifiants

  • HAL Id : hal-04965096 , version 1

Citer

Valerie Cormier-Daire, Shelda Cohen, Thomas Edouard, Bertrand Isidor, Swati Mukherjee, et al.. Real-world experience with Vosoritide for achondroplasia: interim findings from an early access programme in France. 60th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), Sep 2022, Rome, Italy. pp.308-309. ⟨hal-04965096⟩
45 Consultations
0 Téléchargements

Partager

  • More